BiomX Statistics

Total Valuation

BiomX has a market cap or net worth of $20.59 million. The enterprise value is -$13.40 million.

Market Cap	20.59M
Enterprise Value	-13.40M

Important Dates

The next estimated earnings date is Wednesday, August 7, 2024, before market open.

Earnings Date	Aug 7, 2024
Ex-Dividend Date	n/a

Share Statistics

BiomX has 69.81 million shares outstanding. The number of shares has increased by 93.90% in one year.

Shares Outstanding	69.81M
Shares Change (YoY)	+93.90%
Shares Change (QoQ)	+2.57%
Owned by Insiders (%)	10.47%
Owned by Institutions (%)	12.87%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.40

Current Ratio	4.40
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12.80

Financial Efficiency

Return on equity (ROE) is -846.10% and return on invested capital (ROIC) is -4,469.83%.

Return on Equity (ROE)	-846.10%
Return on Assets (ROA)	-82.10%
Return on Capital (ROIC)	-4,469.83%
Revenue Per Employee	n/a
Profits Per Employee	-$523,028
Employee Count	71
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BiomX has paid $22,000 in taxes.

Income Tax	22,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.59% in the last 52 weeks. The beta is 1.31, so BiomX's price volatility has been higher than the market average.

Beta (5Y)	1.31
52-Week Price Change	-35.59%
50-Day Moving Average	0.35
200-Day Moving Average	0.32
Relative Strength Index (RSI)	37.01
Average Volume (20 Days)	107,254

Short Selling Information

The latest short interest is 1.06 million, so 1.52% of the outstanding shares have been sold short.

Short Interest	1.06M
Short Previous Month	1.09M
Short % of Shares Out	1.52%
Short % of Float	n/a
Short Ratio (days to cover)	6.44

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-25.93M
Pretax Income	-37.11M
Net Income	-37.14M
EBITDA	-33.55M
EBIT	-34.42M
Earnings Per Share (EPS)	-$0.61

Full Income Statement

Balance Sheet

The company has $44.12 million in cash and $10.12 million in debt, giving a net cash position of $33.99 million or $0.49 per share.

Cash & Cash Equivalents	44.12M
Total Debt	10.12M
Net Cash	33.99M
Net Cash Per Share	$0.49
Equity (Book Value)	-9.54M
Book Value Per Share	-0.14
Working Capital	36.39M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$27.60 million and capital expenditures -$39,000, giving a free cash flow of -$27.64 million.

Operating Cash Flow	-27.60M
Capital Expenditures	-39,000
Free Cash Flow	-27.64M
FCF Per Share	-$0.44

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BiomX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-93.90%
Shareholder Yield	-93.90%
Earnings Yield	-180.33%
FCF Yield	-134.20%

Analyst Forecast

The average price target for BiomX is $2.25, which is 662.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.25
Price Target Difference	662.71%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-10.32%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3